Radioimmunoassay for melatonin [PMID: 7411138] Laboratory literature summary: Radioimmunoassay for melatonin
Treating Fatty Liver Disease: GLP-1 receptor agonists have shown promise in managing non-alcoholic fatty liver disease
This condition prevents the stomach from emptying properly, leading to chronic nausea, vomiting, abdominal pain, and early satiety
Lopaschuk (2021) Targeting the Brain to Protect the Heart JACC: Basic to Translational Science, Volume 6, Issue 1, January 2021, Pages 71-73
Contains no sugar
Benefits of Semaglutide Reduces food intake by lowering appetite Promotes satiety and fullness by slowing food digestion in the stomach Decreases body fat percentage through loss of visceral adipose tissue and belly fat Weight loss with decreased waist size (majority of patients lost at least 15% body weight) Improves cardiovascular risk profile including lowering cholesterol, inflammation, blood pressure and blood sugar Lowers HbA1c Enhances growth of B cells in the pancreas Prevents cognitive decline Side effects can include: Nausea, Vomiting, Abdominal Bloating, Lack of appetite, Diarrhea, and Constipation
